Abstract
Importance of growth factor (GF) signaling in cancer progression is widely acknowledged. Transforming growth factor beta (TGFβ) is known to play a key role in epithelial-to-mesenchymal transition (EMT) and metastatic cell transformation that are characterized by alterations in cell mechanical architecture and behavior towards a more robust and motile single cell phenotype. However, mechanisms mediating cancer type specific enhancement of cell mechanical phenotype in response to TGFβ remain poorly understood. Here, we combine high-throughput mechanical cell phenotyping, microarray analysis and gene-silencing to dissect cytoskeletal mediators of TGFβ-induced changes in mechanical properties of on-small-cell lung carcinoma (NSCLC) cells. Our experimental results show that elevation of rigidity and invasiveness of TGFβ-stimulated NSCLC cells correlates with upregulation of several cytoskeletal and motor proteins including vimentin, a canonical marker of EMT, and less-known unconventional myosins. Selective probing of gene-silenced cells lead to identification of unconventional myosin MYH15 as a novel mediator of elevated cell rigidity and invasiveness in TGFβ-stimulated NSCLC cells. Our experimental results provide insights into TGFβ-induced cytoskeletal remodeling of NSCLC cells and suggest that mediators of elevated cell stiffness and migratory activity such as unconventional cytoskeletal and motor proteins may represent promising pharmaceutical targets for restraining invasive spread of lung cancer.
Introduction
Metastasis remains the primary cause of mortality in non-small-cell lung cancer (NSCLC). Central to this process is the Epithelial-to-Mesenchymal Transition (EMT), where stationary tumor cells transform into mobile, invasive entities. While conventional wisdom often suggests that metastatic cells soften to navigate tight tissue spaces, recent findings point toward a "stiffness paradox": some cells may require increased rigidity to generate the forces necessary to penetrate dense extracellular matrices. This study investigates how Transforming Growth Factor Beta (TGFβ) alters the mechanical architecture of NSCLC cells and identifies the genetic drivers behind these changes.
Methodology
The researchers utilized a "phenotype-to-genotype" strategy to dissect the mechanical response of NSCLC cells:
- Microfluidic Optical Stretcher (MOS): This non-contact tool uses dual laser beams to trap and stretch individual cells, measuring "cell strain" (deformability) at high throughput.
- Transcriptome and Genetic Analysis: Microarray profiling tracked gene expression changes over 48 hours post-stimulation. Candidate genes were subsequently silenced using siRNA to determine their role in cell mechanics.
- Functional Assays: Cell motility was assessed via 2D time-lapse microscopy, while 3D collagen gel assays measured invasive capacity.
Results
The Stiffness Paradox and Morphological Shifts
Contrary to the "softer is more invasive" hypothesis, TGFβ stimulation resulted in a 34% increase in cell rigidity across multiple NSCLC cell lines (H1975, H1650, H2030) and primary patient samples. This mechanical hardening was accompanied by significant increases in both cell diameter and nuclear area, suggesting a more robust and metabolically active phenotype.
MYH15: A Novel Mechanical Mediator
While both TGFβ and Hepatocyte Growth Factor (HGF) were tested, TGFβ exhibited a significantly stronger influence on cell mechanics. Through gene-silencing experiments, the team identified the unconventional myosin MYH15 as a critical driver. Silencing MYH15 prevented the TGFβ-induced stiffening and significantly reduced the cells' ability to invade 3D matrices. Interestingly, the stiffening was not due to an increase in total actin filaments but rather enhanced crosslinking of the existing cytoskeleton, likely driven by proteins like MYH15 and MYL9.
Discussion
This research highlights that increased mechanical robustness is a hallmark of the invasive mesenchymal phenotype in lung cancer. The identification of MYH15 as a master switch for this mechanical transformation offers a potential new therapeutic target. However, the authors note that optical deformability is a complex metric and that the "soft vs. stiff" debate likely depends on the specific microenvironmental context. Future work will need to address how these cells interact with substrates of varying stiffness and the challenges of developing specific inhibitors for unconventional myosins.
Summary updated